Unless the CEO had a privately owned company that would benefit from all those NWBO research dollars.... right?
I think they have their hands full with figuring out how the Aug and Sep 1st bills are going to get paid and how to break the imminent news to shareholders about a potential large offering, reverse split, or an increase in authorized shares, and how they are planning all new trials that are already past the projected start date. (Q2, 2025 as per SEC filing)
Market Data 
Markets 
AI
